September 1, 2012
View Full PaperMedtronic CoreValve Evolut valve
Key Result
The first implantation of the 23 mm CoreValve Evolut bioprosthesis was successfully performed in a 93-year-old female patient with aortic stenosis.
Study Design
Type
Case Report (n=1)
Multicenter
No
Structured PICO
P
Population
1 93-year-old female patient with aortic stenosis
I
Intervention
23 mm CoreValve Evolut bioprosthesis implantation
This case report describes the first implantation of the 23 mm CoreValve Evolut in a patient with aortic stenosis.
Abstract
The first member of the next generation CoreValve "family" is the 23 mm CoreValve® Evolut™ (Medtronic, Minneapolis, MN, USA), which is indicated for an annulus range of 18 mm to 20 mm and extends the spectrum of patients with aortic stenosis that can be treated with the self-expanding CoreValve bioprosthesis. The Core-Valve Evolut provides several technical refinements and is designed to enable re-capturability in the future. Here, we report on the first case in a 93-year-old female patient who was implanted at the University Hospital Bonn, Germany, on June 1st, 2012.